Fatty Liver / MASLD
Fatty liver disease is not benign.
In some patients, it progresses to MASLD and NASH, leading to fibrosis, cirrhosis, and liver failure.
Weight loss alone is not always enough.
Treatment must address metabolism, insulin resistance, and inflammation.
Fatty liver requires structured, long-term medical care — not crash diets.
#FattyLiver
#MASLD
#NASH
#MetabolicHealth
#LiverDisease
#PreventCirrhosis
#LiverHealth
#DrChetanKalal